Long-term administration of tibolone plus gonadotropin-releasing hormone agonist for the treatment of uterine leiomyomas: effectiveness and effects on vasomotor symptoms, bone mass, and lipid profiles - influence on markers of cardiovascular disease

By Palomba S.   Affinito P.   Di Carlo C.   Bifulco G.   Nappi C.  

Fertility and Sterility, Vol. 72, Iss. 5, 1999-11 ,pp. : 889-895

Elsevier

Access to resources Recommend Favorite

Successful pregnancy after gonadotropin-releasing hormone analogue and hysteroscopic myomectomy in a woman with diffuse uterine leiomyomatosis

By Shimizu Yoshihiko  

Archives of Gynecology and Obstetrics, Vol. 280, Iss. 1, 2009-07 ,pp. : 145-147

Springer Publishing Company

Access to resources Recommend Favorite

Long-term remission of ovarian hyperandrogenism after short-term treatment with a gonadotropin-releasing hormone agonist

By Efstathiadou Z.   Tsatsoulis A.  

Fertility and Sterility, Vol. 75, Iss. 1, 2001-01 ,pp. : 59-62

Elsevier

Access to resources Recommend Favorite

Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial

By Vercellini P.   Trespidi L.   Zaina B.   Vicentini S.   Stellato G.   Crosignani P.G.  

Fertility and Sterility, Vol. 79, Iss. 6, 2003-06 ,pp. : 1390-1395

Elsevier

Access to resources Recommend Favorite

Effects of functional ovarian cysts detected on the 7th day of gonadotropin-releasing hormone analog administration on the outcome of IVF treatment

By Biljan M.M.   Lapensee L.   Mahutte N.G.   Bissonnette F.   Hemmings R.   Tan S.L.  

Fertility and Sterility, Vol. 74, Iss. 5, 2000-11 ,pp. : 941-945

Elsevier

Access to resources Recommend Favorite